Archives

by in
Entry Author Date Location
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
In Its Bumpy Second Life, Geron Signs Top Drug Over to J&J 11/13/14 San Francisco
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
Progress for Pervasis and InVivo: A Boost for Regenerative Efforts? 04/19/12 Boston
Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline 07/01/11 New York
Axonia Seeks to Regenerate Nerves a New Way, Sidestepping Stem Cell Controversy 01/25/11 Detroit
InVivo Completes Reverse Merger, Raising $10.5M 10/27/10 Boston
When Good Doctors Make Bad Decisions—The View from the Jury Box 03/26/10 National
InVivo CEO Overcame Spinal Cord Injury, Now Aims to Create Better Treatment For Same Problem 12/05/08 Boston
Page 1 of 1